Abstract
The objective of the study was to examine the measurement properties of and comparability between the English and Chinese versions of the Functional Assessment of Cancer Therapy—Breast (FACT-B) in breast cancer patients in Singapore. This is an observational study of 271 Singaporean breast cancer patients. The known-group validity of FACT-B total score and Trial Outcome Index (TOI) were assessed in relation to performance status, evidence of disease, and treatment status cross-sectionally; responsiveness to change was assessed in relation to change in performance status longitudinally. Internal consistency and test–retest reliability were evaluated by the Cronbach’s alpha and intraclass correlation coefficient (ICC), respectively. Multiple regression analyses were performed to compare the scores on the two language versions, adjusting for covariates. The FACT-B total score and TOI demonstrated known-group validity in differentiating patients with different clinical status. They showed high internal consistency and test–retest reliability, with Cronbach’s alpha ranging from 0.87 to 0.91 and ICC ranging from 0.82 to 0.89. The English version was responsive to the change in performance status. The Chinese version was shown to be responsive to decline in performance status but the sample size of Chinese-speaking patients who improved in performance status was too small (N = 6) for conclusive analysis about responsiveness to improvement. Two items concerning sexuality had a high item non-response rate (50.2 and 14.4%). No practically significant difference was found in the total score and TOI between the two language versions despite minor differences in two of the 37 items. The English and Chinese versions of the FACT-B are valid, responsive, and reliable instruments in assessing health-related quality of life in breast cancer patients in Singapore. Data collected from the English and Chinese versions can be pooled and either version could be used for bilingual patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jara-Lazaro AR, Thilagaratnam S, Tan PH (2010) Breast cancer in Singapore: some perspectives. Breast Cancer 17:23–28
Chia KS, Reilly M, Tan CS, Lee J, Pawitan Y, Adami HO et al (2005) Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113:302–305
Tey J, Baggarley S, Lee KM (2008) Cancer care in Singapore. Biomed Imaging Interv J 4:e38
Cella D (1997) FACIT manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system. CORE, Evanston
Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcome 1:79
Brady M, Cella D, Mo F, Bonomi AE, Tulsky DS, Lloyd SR et al (1997) Reliability and validity of the Functional Assessment of Cancer Therapy—Breast quality-of-life instrument. J Clin Oncol 15:974–986
Yoo HJ, Ahn SH, Eremenco S et al (2005) Korean translation and validation of the functional assessment of cancer therapy-breast (FACT-B) scale version 4. Qual Life Res 14:1627–1632
Pandey M, Thomas BC, Ramdas K, Eremenco S, Nair MK (2002) Quality of life in breast cancer patients: validation of a FACT-B Malayalam version. Qual Life Res 11:87–90
Wan C, Zhang D, Yang Z, Tu X, Tang W, Feng C et al (2007) Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat 106:413–418
U.S. Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. FDA, 2009. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf, Accessed 14, June 2011
Graddol D (2004) The future of language. Science 303:1329–1331
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655
Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J (2005) Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. JCO 23:4936–4944
Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D (2003) Performance status score: do patients and their oncologists agree? Br J Cancer 89:1022–1027
Cuzick J (1985) A Wilcoxon-type test for trend. Stat Med 4:87–90
Cheung YB, Thumboo J, Goh C, Khoo KS, Che W, Wee J (2004) The equivalence and difference between the English and Chinese versions of two major cancer-specific health-related quality of life questionnaires. Cancer 101:2874–2880
Cheung YB, Goh C, Wee J, Khoo KS, Thumboo J (2009) Measurement properties of the Chinese language version of the Functional Assessment of Cancer Therapy—General in a Singaporean population. Ann Acad Med Singapore 38:225–229
Cheung YB, Daniel R, Ng GY (2006) Response and non-response to a quality-of-life question on sexual life: a case study of the simple mean imputation method. Qual Life Res 15:1493–1501
Mehta CR, Patel NR (1983) A network algorithm for performing Fisher’s exact test in r × c contingency tables. JASA 78:427–434
Acknowledgment
The study was funded by National Medical Research Council, Singapore (NMRC/EDG/0063/2009).
Conflict of interest
The author declare that they have no potential conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ng, R., Lee, C.F., Wong, N.S. et al. Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy—Breast (FACT-B) in Asian breast cancer patients. Breast Cancer Res Treat 131, 619–625 (2012). https://doi.org/10.1007/s10549-011-1764-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1764-z